$SNPS

Synopsys (SNPS) Q3 2026 Earnings Call Transcript

Synopsys (SNPS) reported Q3 2026 earnings, highlighting strong growth in Design Automation and Ansys integration. The company launched Multiphysics Fusion, driving demand for AI-driven chip design solutions. Revenue was $2.477B, beating guidance, with non-GAAP EPS of $3.91. The company raised full-year guidance due to strong performance and momentum.

Original reporting
Published Aug 31, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 31, 2026, 3:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Synopsys (SNPS) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

Earnings beat and guidance raise could trigger a short-term rally, while long-term growth hinges on AI and agentic workflows.

02

Market read

Strong earnings and forward guidance reinforce SNPS as a beneficiary of AI-driven semiconductor design demand.

03

What to watch

Potential integration challenges of Ansys joint solutions and capital intensity of AI investments.

Relevance 9/10Novelty 9/10Timing: post-earnings release

Background

Synopsys' Q3 earnings call covered record hardware revenue, AI-driven demand, and new joint solutions with Ansys.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys reported Q3 2026 revenue of $2.477B, EPS $3.91 and raised full-year guidance, a fresh earnings disclosure.

Expected impact

Potential short-term price rally on earnings beat and guidance raise.

Evidence & confidence

First report of earnings with strong numbers and upward guidance typically drives buying pressure.

Market effects

Positive earnings may lift broader EDA and semiconductor design software sector.

U.S. tech stocks could see modest gains.

Highlights AI-driven demand for design tools worldwide.

Counterpoint

Guidance raise may already be priced in; focus on execution risk of new AI initiatives.

Key entities

  • Synopsys

    Provider of EDA and IP solutions, ticker SNPS.

  • Ansys

    Partner in joint Multiphysics Fusion solution.

Related articles

$SNPSMedAI 8/10

Why Has Synopsys Stopped Leading With Bad News?

Synopsys (SNPS) shifted its earnings call focus from past issues, like China's export restrictions and IP business underperformance, to new growth areas like Multiphysics Fusion with Ansys and agentic AI. Design Automation grew to $7.7-7.9B, while Design IP remained at $1.8B. Management expects new initiatives to boost EDA growth in 2027, but Design IP's turnaround is based on a single quarter of growth.

$SNPSMed

SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Morgan Stanley upgraded Synopsys (SNPS) to Overweight, maintaining a $500 price target. The stock is trading at $396.11, which is 39.9% undervalued according to its GF Value™ of $659.20. Synopsys has a GF Score™ of 88/100, indicating strong growth potential but concerns about valuation. Insider activity shows significant selling, with $40.7 million in sales over the last three months.

$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.